Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Nurses' insights could transform phlebitis care in ICUs

NCT ID NCT07051798

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study explores the experiences of 20 intensive care nurses in managing phlebitis, a painful vein inflammation often caused by IV lines. Through face-to-face interviews, researchers aim to uncover common challenges and helpful strategies. The goal is to improve prevention and care practices, ultimately boosting patient safety.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help hospitals improve how they prevent and manage phlebitis, leading to better patient safety and nurse training.
What could go wrong
This is a small, early-stage qualitative study with only 20 nurses from one hospital. The findings may not apply to other settings or lead to direct changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

20 people

The number who actually took part.

Started

Jul 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Intensive Care nurses

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Voluntarily accepting to participate in the study * Being the primary nurse of a patient who developed phlebitis, * Having at least 1 year of work experience. Exclusion Criteria: * Being assigned to the unit for a short period of time * Being on leave or sick leave, * Not accepting to participate in the study, * Leaving the study during the data collection process.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nursi̇NG care are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kutahya Health Sciences University

    Kütahya, Kütahya, 43000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.